Why the study?
Does mitral valve replacement improve survival and symptoms in patients with severe mitral regurgitation due to ruptured papillary muscle post-myocardial infarction?
Does mitral valve replacement improve survival and symptoms in patients with severe mitral regurgitation due to ruptured papillary muscle post-myocardial infarction?
Mitral valve replacement can provide survival and symptomatic benefit in patients with severe heart failure due to post-infarction papillary muscle rupture.
Answers are grounded in this paper and cite their sources.
May support MVR consideration in select post-MI papillary muscle rupture; leaves open need for larger controlled studies before practice change.
The results of operative treatment are described in four patients who sustained myocardial infarctions and in whom ruptured left ventricular papillary muscles caused severe mitral regurgitation. All were men between 51 and 69 years of age, and the intervals between myocardial infarction and operation were 3 to 15 months. Each patient manifested severe congestive heart failure. All were in sinus rhythm and had an apical holosystolic murmur and an atrial gallop sound. Three of the four had severe pulmonary hypertension (60 to 80 mm Hg systolic), grossly elevated mean left atrial pressure, and v waves 37 to 45 mm Hg. In all the cardiac index was abnormally low (average 1.8 L/min/m2). In all four patients the mitral valve was replaced with a 2M Starr-Edwards prosthesis. In two of the excised valves, one head of the posterior papillary muscle was infarcted and had ruptured, and in the other two the anterior papillary muscle was similarly involved. All patients survived, and all have derived distinct symptomatic improvement at intervals of 7 to 16 months. Hemodynamic studies were repeated 11 months postoperatively in one patient; although he is asymptomatic and the cardiac index is increased, intracardiac pressures remain elevated, and residual impairment of left ventricular function is evident. In a second patient the left ventricle apparently retained satisfactory functional capacity for symptomatic benefit has been paralleled by striking reductions in pulmonary arterial and left atrial pressures measured six months postoperatively.
No takes yet. Share an insight, caveat, or question.
Morrow et al. (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: